William Mckee is Chief Financial Officer of C4 Therapeutics, Inc.. Currently has a direct ownership of 5,263 shares of CCCC, which is worth approximately $33,841. The most recent transaction as insider was on Oct 06, 2020, when has been sold 5,263 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $99,997. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.26K
0% 3M change
0% 12M change
Total Value Held $33,841

WILLIAM MCKEE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 06 2020
BUY
Open market or private purchase
$99,997 $19.0 p/Share
5,263 Added 50.0%
5,263 Common Stock

Also insider at

ASRT
Assertio Holdings, Inc. Healthcare
ALRN
AILERON THERAPEUTICS INC Healthcare
WM

William Mckee

Chief Financial Officer
Watertown, MA

Track Institutional and Insider Activities on CCCC

Follow C4 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCCC shares.

Notify only if

Insider Trading

Get notified when an C4 Therapeutics, Inc. insider buys or sells CCCC shares.

Notify only if

News

Receive news related to C4 Therapeutics, Inc.

Track Activities on CCCC